Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Suisse (CSUI) Common Equity (2016 - 2026)

Cannabis Suisse (CSUI) has disclosed Common Equity for 10 consecutive years, with -$1.8 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 5.87% to -$1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.8 million through Nov 2025, up 5.87% year-over-year, with the annual reading at -$1.8 million for FY2025, 33.89% down from the prior year.
  • Common Equity for Q4 2025 was -$1.8 million at Cannabis Suisse, up from -$1.8 million in the prior quarter.
  • The five-year high for Common Equity was -$187494.0 in Q2 2021, with the low at -$1.9 million in Q3 2024.
  • Average Common Equity over 5 years is -$805909.6, with a median of -$356825.5 recorded in 2023.
  • The sharpest move saw Common Equity soared 54.19% in 2021, then plummeted 389.56% in 2024.
  • Over 5 years, Common Equity stood at -$293634.0 in 2021, then grew by 22.99% to -$226129.0 in 2022, then plummeted by 80.87% to -$409001.0 in 2023, then crashed by 358.64% to -$1.9 million in 2024, then increased by 5.87% to -$1.8 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at -$1.8 million, -$1.8 million, and -$1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.